PREDICTORS OF VENTRICULAR FIBRILLATION IN ST ELEVATION MYOCARDIAL INFARCTION
Abstract
To reveal predictors of ventricular fibrillation in patients with ST elevation myocardial infarction who received primary angioplasty, the analysis of the data of 1,718 patients (men: 70%) aged 66±12 years admitted to Lund University Hospital in 2007-2009 was made.
About the Authors
M. M. Demidova
ФГБУ Северо-Западный Федеральный Исследовательский Центр им. В.А.Алмазова
Russian Federation
Russian Federation
D. .. Erlinge
Лундский Университет
Russian Federation
Russian Federation
P. G. Platonov
Лундский Университет
Russian Federation
Russian Federation
References
1. Volpi A, Cavalli A, Santoro L, Negri E. Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction - results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GIS- SI-2) database. Am J Cardiol. 1998;82(3):265-71. Epub 1998/08/26.
2. Norris RM. Fatality outside hospital from acute coronary events in three British health districts, 1994-5. United Kingdom Heart Attack Study Collaborative Group. BMJ. 1998;316(7137):1065-70. Epub 1998/04/29.
3. Zipes DP, Camm AJ, Borggrefe M et al. ACC/AHA/ ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J. 2006;27(17):2099-140. Epub 2006/08/23.
4. Stenestrand U, Wallentin L. Early statin treatment following acute myocardial infarction and 1-year survival. JAMA. 2001;285(4):430-6. Epub 2001/03/10.
5. Stenestrand U, Wijkman M, Fredrikson M, Nys- trom FH. Association between admission supine systolic blood pressure and 1-year mortality in patients admitted to the intensive care unit for acute chest pain. JAMA. 2010;303(12):1167-72. Epub 2010/03/25.
6. Milonas C, Jernberg T, Lindback J et al. Effect of Angiotensin-converting enzyme inhibition on one-year mortality and frequency of repeat acute myocardial infarction in patients with acute myocardial infarction. Am J Cardiol. 2010;105(9):1229-34. Epub 2010/04/21.
7. Frobert O, Lagerqvist B, Gudnason T et al. Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia (TASTE trial). A multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish angiography and angioplasty registry (SCAAR) platform. Study design and rationale. Am Heart J. 2010;160(6):1042-
8. Epub 2010/12/15.
9. Stenestrand U, James SK, Lindback J et al. Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur Heart J. 2010;31(2):177-86. Epub 2009/11/12.
10. Behar S, Goldbourt U, Reicher-Reiss H, Kaplinsky E. Prognosis of acute myocardial infarction complicated by primary ventricular fibrillation. Principal Investigators of the SPRINT Study. Am J Cardiol. 1990;66(17):1208-11. Epub 1990/11/15.
11. Newby KH, Thompson T, Stebbins A et al. Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. The GUSTO Investigators. Circulation. 1998;98(23):2567-73. Epub 1998/12/08.
12. Mehta RH, Starr AZ, Lopes RD et al. Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. JAMA. 2009;301(17): 1779-89. Epub 2009/05/07.
13. Kaneko H, Anzai T, Naito K et al. Role of ischemic preconditioning and inflammatory response in the development of malignant ventricular arrhythmias after reperfused ST-elevation myocardial infarction. J Card Fail. 2009;15(9):775-81. Epub 2009/11/03.
14. Mehta RH, Harjai KJ, Grines L et al. Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors, and outcomes. J Am Coll Cardiol. 2004;43(10):1765-72. Epub 2004/05/18.
15. The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med. 1997;336(8):525-33. Epub 1997/02/20.
16. Ruelaz RA, Rahimtoola SH. Was it digoxin toxicity?..very likely. J Card Fail. 2005;11(2):87-90. Epub and mortality in atrial fibrillation: a prospective cohort 2005/02/26. study. Eur J Clin Pharmacol. 2007;63(10):959-71. Epub
17. Hallberg P, Lindback J, Lindahl B et al. Digoxin 2007/08/09.
Review
For citations:
Demidova M.M., Erlinge D..., Platonov P.G. PREDICTORS OF VENTRICULAR FIBRILLATION IN ST ELEVATION MYOCARDIAL INFARCTION. Journal of Arrhythmology. 2015;(79):64-69. (In Russ.)
Views:
255
Email this article 